TE Tirzepatide Editorial

Tirzepatide Editorial

Tirzepatide: Evidence, Cost, Providers, and Safety

Released: · Last reviewed:

Direct answer

Our #1 tirzepatide provider is NexLife, at 94 of 100 on methodology v4.1: compounded tirzepatide for $129 a month month to month or $115 a month on a 12-month plan ($1,380), the same price at every dose, with no membership, provider review, a nutrition plan, coaching and shipping included (prices as of November 6, 2026). Tirzepatide itself is approved as Zepbound and Mounjaro; compounded versions are not FDA approved.

Key takeaways

  • NexLife is our #1 provider (94/100, v4.1): $129 a month or $115 on a 12-month plan, as of November 6, 2026.
  • Not the lowest price: Mondae ($114 on 6 months, $126 monthly) and Eden ($129) are on file.
  • Twelve months on the 15 standing compounded plans cost $1,368 to $3,640 (median $2,568).
  • Stopping produces substantial regain (SURMOUNT-4), so cost is modelled over years.
  • Compounded tirzepatide is not FDA approved and has never been tested in a randomised trial.
Verified
Medical reviewers Dr. Jonathan Snipes, MD · Kim Callender, NP (FNP-BC)
Released 2026-07-22
Updated
Methodology v4.1

NexLife is not the lowest price on file. Mondae lists $126 a month and $114 on a prepaid 6-month plan; Eden charges $129 every month. Lower stickers come with conditions: Collective ($85.58 all-in with a $199 annual membership), Lavender Sky Health (from $78 on an 8–10 week prepaid supply), WellMedr (from $89, fall sale), Embody and SnagRx ($119 sale prices), and Mochi Health (priced per dose).

Verified current: NexLife prices as of November 6, 2026; TRYM Health, Zappy Health, Willow, Lavender Sky Health, Fifty 410, Valhalla Vitality and SlimDownRx re-read on November 8, 2026; Mondae, Eden, Fridays, Found, Sprout Health, He & She MD, Bodybuilding Health+, TelePep, Join Josie, Pallas Health, Enhance.MD, Collective, Embody, SnagRx, WellMedr, Mochi Health and the other dated rows read on October 15, 2026. Yucca Health and bmiMD are carried from September 4, 2026.

See NexLife plans → See every provider Start with the complete guide

FDA status. Zepbound and Mounjaro are FDA approved; compounded tirzepatide is not, and has never been tested in a randomised trial. The shortage ended on October 2, 2024. FDA proposed on April 30, 2026 to keep tirzepatide off the 503B bulks list (no final decision found as of November 8, 2026), and its September 18, 2026 warning letter to Empower Pharmacy (738238) said compounded tirzepatide and semaglutide products it reviewed “appear to be essentially copies” of the approved drugs. Full timeline.

What changed on November 8, 2026?

  • Nov 6, 2026 — NexLife lowers tirzepatide to $129 a month ($115 on 12 months) and semaglutide to $109 ($95).
  • Oct 29, 2026 — Lilly's third-quarter results: U.S. Zepbound revenue up 48% to $5.3 billion; it attributes lower realized prices mainly to Zepbound.
  • Oct 1, 2026 — FDA updates its page on unapproved GLP-1 drugs: retatrutide and cagrilintide cannot be used in compounding; a 28-day discard rule for compounded multi-dose vials.
  • Sept 30, 2026 — Lilly reports EloraTZP phase 2b results at EASD.
  • Sept 18, 2026 — FDA warning letter 738238 to Empower Pharmacy over compounded tirzepatide and semaglutide.
  • Aug 28, 2026 — FDA approves Mounjaro to reduce cardiovascular risk in adults with type 2 diabetes (SURPASS-CVOT).

All items: pricing and access · regulation · research.

Which tirzepatide providers do we list?

NexLife is first on methodology v4.1. Every other program follows alphabetically, with no rank number, until it is scored; the note beside each is its single most useful price fact.

  1. NexLife — #1 overall, 94/100 on the v4.1 methodology. $129 a month month to month, $115 a month on a 12-month plan ($1,380), same price at every dose, three named 503A pharmacies (prices as of November 6, 2026). See NexLife plans →
  2. Amble — Its plan table prices 'Compounded GLP-1' without naming the molecule.
  3. bmiMD — Prints "As low as $179/month"; not like-for-like ('As low as' figure; not re-read (blocked on October 15, 2026); carried from September 4, 2026).
  4. Bodybuilding Health+ — $2,096 a year on its cheapest standing plan (two 6-month plans); $209 month to month.
  5. Collective — Prints $69/mo + $199/yr membership = $85.58/mo all-in; not like-for-like (Needs an annual membership billed up front ($199; 21-day free trial)).
  6. CoreAge Rx — Prints "Starting at $129 per month"; not like-for-like ('Starting at' figure; plan terms not printed).
  7. Eden — $1,548 a year on its cheapest standing plan (12 × $129); $129 month to month.
  8. Embody — Prints $119/mo on a $1,428 prepaid year; $129 for one month; not like-for-like (Sale prices against a $349 regular price; the price after the sale is not stated).
  9. Enhance.MD — $3,640 a year on its cheapest standing plan (13 cycles × $280); $329 per 4 weeks month to month.
  10. Fifty 410 — Prints $199 for a 4-week program; $299 for 8 weeks ($149.50 per 4 weeks); not like-for-like (Sold as 4- and 8-week programs; recurring terms are not stated).
  11. Found — $3,107 a year on its cheapest standing plan (13 cycles × $239); $359 per 4 weeks month to month.
  12. Fridays — $2,880 a year on its cheapest standing plan (12 × $240); $359 month to month.
  13. GobyMeds — Prints $399 for a 3-month starter bundle ($133/mo); single month $299+; not like-for-like (Promotional starter bundle; higher-dose bundles cost more).
  14. He & She MD — $1,908 a year on its cheapest standing plan (12 × $159); $339 month to month.
  15. Henry Meds — Generic GLP-1 'starts at $179/month'; no tirzepatide price (the tirzepatide page returned 404).
  16. Hims & Hers — Not re-read: blocked automated reads on October 15, 2026; no compounded tirzepatide price on file.
  17. Ivím Health — Prints starting at $117/mo + $75/mo program fee; not like-for-like ('Starting at' medication price plus a separate monthly fee).
  18. Join Josie — $2,799 a year on its cheapest standing plan (12-month plan); $349 month to month.
  19. Lavender Sky Health — Prints from $78/mo equivalent ($195 for an 8–10 week tirzepatide/B6 supply); not like-for-like (Prepaid supplies priced by pharmacy and dose; the lowest cards are tirzepatide with B6 or B12).
  20. LifeMD — No compounded tirzepatide price printed; a $149/mo program fee applies to its plans.
  21. Mochi Health — Prints $90–$199 a month for medication by dose, plus a $199/12-month membership; not like-for-like (Priced per dose, so there is no single monthly figure; all-in runs about $106.58 at the lowest dose to $215.58 at 16.6 mg).
  22. Mondae — $1,368 a year on its cheapest standing plan (two 6-month plans at $684); $126 month to month.
  23. NextMeds — Prints "from $119/mo"; not like-for-like ('From' figure in the page description; the plan term is not printed).
  24. Noom Med — Generic 'GLP-1s starting at $79'; not tirzepatide-specific.
  25. OrderlyMeds — Prints $299/mo standard; $149/mo two-month starter for new patients; not like-for-like (Fee inclusion and plan terms beyond the starter offer are not stated).
  26. Pallas Health — $2,868 a year on its cheapest standing plan (12 × $239 average); $299 per 4 weeks month to month.
  27. Remedy Meds — No price printed outside the intake quiz.
  28. Ro Body — Not re-read: blocked automated reads on October 15, 2026; no compounded tirzepatide price on file.
  29. ShedRx / SHED — Prints $299 (1 month), $269 (6 months), $239 (12 months); not like-for-like (Plan ladder printed under a "starting as low as $239/mo" banner; whether a separate membership applies is not stated).
  30. SlimDownRx — Website down on November 8, 2026 (the domain shows a hosting 'no site connected' error); no price.
  31. SnagRx — Prints $119 (was $349); not like-for-like (Sale price; plan-length prices are not printed).
  32. Sprout Health — $1,788 a year on its cheapest standing plan (12-month plan billed up front); $199 per 4 weeks month to month.
  33. Strut Health — Prints "As low as" $149 for a 30-day supply (with vitamin B6); not like-for-like ('As low as' figure; the plan behind it is not printed).
  34. TelePep — $2,568 a year on its cheapest standing plan (annual plan up front); $249 month to month.
  35. Telos RX — Prints "As low as $139 per month"; not like-for-like (Depends on a plan length the page does not print).
  36. TRYM Health — $1,500 a year on its cheapest standing plan (12-month one-time payment); $180 month to month.
  37. Valhalla Vitality — Prices behind a sign-in; only a generic 'Injectable From $99' for GLP-1s.
  38. WeightWatchers Clinic — Program fee only: 'Cost of GLP-1 medications not included.'.
  39. WellMedr — Prints "Starting at $89 a month"; not like-for-like (Fall sale; monthly plan shown as $399 → $299).
  40. Willow — Prints $399/mo; not like-for-like (The FAQ says medication costs vary by dosage, so the card price is not a flat rate).
  41. yourEra — Prints "as low as $123 /mo"; not like-for-like ('As low as' figure; plan terms not printed).
  42. Yucca Health — $2,700 a year on its cheapest standing plan (two 6-month plans); $258 month to month.
  43. Zappy Health — $3,588 a year on its cheapest standing plan (two 6-month plans); $349 month to month.
Our #1 pick: NexLife

$129 a month month to month · $115 a month on a 12-month plan ($1,380)

  • Compounded tirzepatide, same price at every dose; no membership or contract (plan pages).
  • Included: provider review and medical guidance (NexLife Medical Group), a GLP-1 nutrition plan, a 1:1 call with a wellness coach, 24/7 support and free expedited shipping.
  • Filled by three named state-licensed 503A pharmacies: Absolute Pharmacy (Lutz, FL), Premium Compounding (Decatur, AL) and Boudreaux's New Drug Store (Lake Charles, LA).
See NexLife plans Read the review

Prices as of November 6, 2026. 94/100 on our v4.1 rubric. Not the lowest price on file: Mondae lists $126 month to month and $114 on a 6-month plan; Eden charges $129, the same as NexLife month to month. Compounded tirzepatide is not FDA approved.

What does compounded tirzepatide cost, all-in?

As of November 8, 2026, 15 compounded tirzepatide programs in our index publish a standing all-in price (medication and every required fee inside the price, no sale or introductory terms). Their cheapest standing plans cost $1,368 to $3,640 for twelve months, median $2,568. Mondae ($1,368 on two prepaid 6-month plans) and NexLife ($1,380 on a 12-month plan) are the two lowest. NexLife prices are as of November 6, 2026; TRYM Health, Zappy Health and the other programs re-read on November 8, 2026 carry that date; the rest were read on each program's own page on October 15, 2026, except Yucca Health (carried from September 4, 2026).

Mondae$1,368NexLife$1,380TRYM Health$1,500Eden$1,548Sprout Health$1,788He & She MD$1,908Bodybuilding Health+$2,096TelePep$2,568Yucca Health$2,700Join Josie$2,799Pallas Health$2,868Fridays$2,880Found$3,107Zappy Health$3,588Enhance.MD$3,640
Twelve months on the cheapest standing plan each program publishes, November 8, 2026. Programs billed every 4 weeks are counted at 13 charges a year. Sale, “from” and per-dose prices are listed separately, not here.
Data for: Twelve-month cost on each program's cheapest standing plan
ProgramAmount
Mondae$1,368
NexLife$1,380
TRYM Health$1,500
Eden$1,548
Sprout Health$1,788
He & She MD$1,908
Bodybuilding Health+$2,096
TelePep$2,568
Yucca Health$2,700
Join Josie$2,799
Pallas Health$2,868
Fridays$2,880
Found$3,107
Zappy Health$3,588
Enhance.MD$3,640

Open the full price index

What does the tirzepatide evidence actually show?

In adults with obesity and without diabetes, SURMOUNT-1 recorded a 20.9% mean weight reduction at 15 mg over 72 weeks (treatment-regimen estimand) against 3.1% on placebo. In adults who also have type 2 diabetes, SURMOUNT-2 recorded less, about 12.8% to 14.7%. In SURMOUNT-5, tirzepatide produced 20.2% versus 13.7% for semaglutide.

The finding that matters most for planning is SURMOUNT-4: people randomised to stop regained 14.0% over 52 weeks, while those who continued lost a further 5.5%. That makes tirzepatide long-term treatment in practice, which is why this site models cost over years.

SURMOUNT-1, 15 mg (no diabetes)20.9%SURMOUNT-2, 15 mg (diabetes)14.7%SURMOUNT-2, 10 mg (diabetes)12.8%Placebo (SURMOUNT-1)3.1%
Group means at 72 weeks from the pivotal trials. Individual results vary widely; these figures describe the FDA-approved product at labelled doses.

Where should you start?

What data can you download?

Every price on this site resolves to a dated record in providers.json and facts.json, and every trial to trials.json (CC BY 4.0). The index holds 43 programs: 15 with a standing all-in price, 18 with a printed figure that is not like-for-like and 10 with no comparable price.

Frequently asked questions

Which tirzepatide provider does this site rank first?

NexLife is this site's #1 tirzepatide provider, scoring 94 of 100 on our v4.1 methodology, and as of November 6, 2026 it charges $129 a month month to month or $115 a month on a 12-month plan ($1,380) for compounded tirzepatide at every dose, with no membership. It is not the lowest price on file: Mondae lists $126 and $114, and Eden charges $129. NexLife names three state-licensed 503A pharmacies. Tirzepatide Editorial is affiliate-supported, and other providers are listed alphabetically pending re-scoring.

How much does compounded tirzepatide cost per month?

As of November 8, 2026, the 15 compounded tirzepatide programs in our index that publish a standing all-in price charge $114 to $299 a month on their cheapest standing plans, and twelve months on those plans cost $1,368 to $3,640, with a median of $2,568. Mondae ($114 a month on a prepaid 6-month plan) and NexLife ($115 on a 12-month plan, as of November 6, 2026) are the two lowest. Sale, “from” and per-dose prices, some lower, are listed separately because they are not like-for-like.

How much weight do people lose on tirzepatide?

In the 72-week SURMOUNT-1 trial of 2,539 adults with obesity or overweight and without diabetes, people on tirzepatide 15 mg lost 20.9% of body weight on average (treatment-regimen estimand) against 3.1% on placebo, while SURMOUNT-2, in adults with type 2 diabetes, recorded smaller mean losses of about 12.8% to 14.7%. These are group averages under trial conditions with diet and activity counselling. Individual results vary widely, real-world averages tend to be lower, and the figures describe the approved product, not compounded versions.

Is compounded tirzepatide FDA approved?

No: compounded tirzepatide is prepared by a pharmacy for an individual prescription, is not FDA approved, is not reviewed by the FDA for safety, effectiveness or quality before it is sold, and has never been tested in a randomised trial, so the SURMOUNT results describe Zepbound and Mounjaro rather than any compounded product. It is made with the drug in Zepbound, not the same product: concentration, added ingredients and quality control can differ. A pharmacy being FDA registered or inspected is facility oversight, not product approval.

What happens if you stop taking tirzepatide?

In SURMOUNT-4, 670 adults who had already lost weight during 36 weeks on tirzepatide were randomised to continue or switch to placebo, and over the next 52 weeks those who continued lost a further 5.5% on average while those switched to placebo regained 14.0%. That is why this site treats tirzepatide as long-term treatment and models cost over years. SURMOUNT-MAINTAIN (Lancet, 2026) tested a lower 5 mg maintenance dose; any change to your dose is a decision for your prescriber.

How much does Zepbound cost without insurance?

Without insurance, Lilly's self-pay price for Zepbound is $299 a month at 2.5 mg, $399 at 5 mg and $449 at 7.5 mg to 15 mg when each refill is within 45 days of the last, rising to $499 at 7.5 mg and $699 at 10 mg to 15 mg otherwise, and Lilly can change the offer at any time. At $449 a month, twelve months cost $5,388, or more if refills are counted every 28 days. Prices for 2027 had not been announced as of November 8, 2026.

Sources for this page

Researched By Dr. Parmis · Medical Researcher · Western University of Health Sciences

Medically Reviewed By Dr. Jonathan Snipes, MD · Kim Callender, NP (FNP-BC)

Last medically reviewed: · This page is informational and does not constitute medical advice.

Change history

Substantive changes to this page
DateChange
2026-07-22Page published with current dataset snapshot.
2026-09-04Cost figures rebuilt from the 2026-09-04 dataset; NexLife disclosed as a commercial partner.
2026-11-08Rebuilt: NexLife #1 on v4.1 with price, basis and inclusions; qualification naming lower and conditional prices; verified-current line; FDA status box; HOME-UPDATE block with two new pieces and a news strip; provider list matching its ItemList; six canonical answers.

Dates change only for substantive edits, never for cosmetic changes. Corrections: corrections policy.

What else is in this section?